Literature DB >> 18791707

Quality and timeliness in medical laboratory testing.

Ingolf Schimke1.   

Abstract

In terms of testing, modern laboratory medicine can be divided into centralized testing in central laboratories and point-of-care testing (POCT). Centralized laboratory medicine offers high-quality results, as guaranteed by the use of quality management programs and the excellence of the staff. POCT is performed by clinical staff, and so such testing has moved back closer to the patient. POCT has the advantage of shortening the turnaround time, which potentially benefits the patient. However, the clinical laboratory testing expertise of clinical staff is limited. Consequently, when deciding which components of laboratory testing must be conducted in central laboratories and which components as POCT (in relation to quality and timeliness), it will be medical necessity, medical utility, technological capabilities and costs that will have to be ascertained. Provided adequate quality can be guaranteed, POCT is preferable, considering its timeliness, when testing vital parameters. It is also preferred when the central laboratory cannot guarantee the delivery of results of short turn-around-time (STAT) markers within 60 or (even better) 30 min. POCT should not replace centralized medical laboratory testing in general, but it should be used in cases where positive effects on patient care have been clearly demonstrated.

Entities:  

Mesh:

Year:  2008        PMID: 18791707     DOI: 10.1007/s00216-008-2349-5

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  10 in total

Review 1.  Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review.

Authors:  Rajesh Rajendran; Gerry Rayman
Journal:  J Diabetes Sci Technol       Date:  2014-06-05

Review 2.  A systematic review of triage-related interventions to improve patient flow in emergency departments.

Authors:  Sven Oredsson; Håkan Jonsson; Jon Rognes; Lars Lind; Katarina E Göransson; Anna Ehrenberg; Kjell Asplund; Maaret Castrén; Nasim Farrohknia
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-19       Impact factor: 2.953

Review 3.  Mapping turnaround times (TAT) to a generic timeline: a systematic review of TAT definitions in clinical domains.

Authors:  Bernhard Breil; Fleur Fritz; Volker Thiemann; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2011-05-24       Impact factor: 2.796

Review 4.  Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies.

Authors:  Luc Bissonnette; Michel G Bergeron
Journal:  J Pers Med       Date:  2012-05-02

Review 5.  Overcrowding in emergency departments: A review of strategies to decrease future challenges.

Authors:  Mohammad H Yarmohammadian; Fatemeh Rezaei; Abbas Haghshenas; Nahid Tavakoli
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

6.  Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.

Authors:  Daan J Touw; Giovanni B Migliori; Jan-Willem Alffenaar; Simone Hj van den Elsen; Marieke Gg Sturkenboom; Onno Akkerman; Linda Barkane; Judith Bruchfeld; Geoffrey Eather; Scott K Heysell; Henadz Hurevich; Liga Kuksa; Heinke Kunst; Johanna Kuhlin; Katerina Manika; Charalampos Moschos; Stellah G Mpagama; Marcela Muñoz Torrico; Alena Skrahina; Giovanni Sotgiu; Marina Tadolini; Simon Tiberi; Francesca Volpato; Tjip S van der Werf; Malcolm R Wilson; Joaquin Zúñiga
Journal:  BMJ Open       Date:  2020-06-16       Impact factor: 2.692

7.  Pre-analytical error for three point of care venous blood testing platforms in acute ambulatory settings: A mixed methods service evaluation.

Authors:  Thomas R Fanshawe; Margaret Glogowska; George Edwards; Philip J Turner; Ian Smith; Rosie Steele; Caroline Croxson; Jordan S T Bowen; Gail N Hayward
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

8.  In-depth investigation of turn-around time of full blood count tests requested from a clinical haematology outpatient department in Cape Town, South Africa.

Authors:  Leonard Mutema; Zivanai Chapanduka; Fungai Musaigwa; Nomusa Mashigo
Journal:  Afr J Lab Med       Date:  2021-04-29

9.  MEMS Biosensors and COVID-19: Missed Opportunity.

Authors:  Thierry Leïchlé; Liviu Nicu; Thomas Alava
Journal:  ACS Sens       Date:  2020-10-19       Impact factor: 7.711

10.  Effectiveness of a Mobile App in Reducing Therapeutic Turnaround Time and Facilitating Communication between Caregivers in a Pediatric Emergency Department: A Randomized Controlled Pilot Trial.

Authors:  Frederic Ehrler; Carlotta Tuor; Remy Trompier; Antoine Berger; Michael Ramusi; Robin Rey; Johan N Siebert
Journal:  J Pers Med       Date:  2022-03-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.